πŸ‡ΊπŸ‡Έ FDA
Patent

US 7339064

Benzimidazole compound crystal

granted A61KA61K31/4439A61P

Quick answer

US patent 7339064 (Benzimidazole compound crystal) held by Takeda Pharmaceutical Company Limited expires Mon Feb 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Mar 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/4439, A61P, A61P1/00, A61P1/04